Literature DB >> 15448352

Selected amino acid substitutions in the C-terminal region of human immunodeficiency virus type 1 capsid protein affect virus assembly and release.

Samir Abdurahman1, Stefan Höglund2, Laura Goobar-Larsson3, Anders Vahlne1.   

Abstract

The capsid protein (CA or p24) of human immunodeficiency virus type 1 (HIV-1) plays a major role both early and late in the virus replication cycle. Many studies have suggested that the C-terminal domain of this protein is involved in dimerization and proper assembly of the viral core. Point mutations were introduced in two conserved sites of this region and their effects on viral protein expression, particle assembly and infectivity were studied. Eight different mutants (L205A+P207A, L205A, P207A, 223GPG225AAA, G223A, P224A, G225A and V221G) of the infectious clone pNL4-3 were constructed. Most substitutions had no substantial effect on HIV-1 protein synthesis, yet they impaired viral infectivity and particle production. The two mutants P207A and V221G also had a profound effect on Gag-Pol protein processing in HeLa-tat cells. However, these results were cell line-specific and Gag-Pol processing of P207A was not affected in 293T cells. In HeLa-tat cells, no virus particles were detected with the P207A mutation, whereas the other mutant virus particles were heterogeneous in size and morphology. None of the mutants showed normal, mature, conical core structures in HeLa-tat cells. These results indicate that the two conserved sequences in the C-terminal CA domain are essential for proper morphogenesis and infectivity of HIV-1 particles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448352     DOI: 10.1099/vir.0.80137-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  A cell-penetrating helical peptide as a potential HIV-1 inhibitor.

Authors:  Hongtao Zhang; Qian Zhao; Shibani Bhattacharya; Abdul A Waheed; Xiaohe Tong; Anita Hong; Susanne Heck; Francesca Curreli; Michael Goger; David Cowburn; Eric O Freed; Asim K Debnath
Journal:  J Mol Biol       Date:  2008-03-06       Impact factor: 5.469

Review 2.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

3.  Simulated self-assembly of the HIV-1 capsid: protein shape and native contacts are sufficient for two-dimensional lattice formation.

Authors:  Bo Chen; Robert Tycko
Journal:  Biophys J       Date:  2011-06-22       Impact factor: 4.033

Review 4.  HIV type 1 Gag as a target for antiviral therapy.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-21       Impact factor: 2.205

5.  Annexin 2: a novel human immunodeficiency virus type 1 Gag binding protein involved in replication in monocyte-derived macrophages.

Authors:  Elena V Ryzhova; Robin M Vos; Andrew V Albright; Alexia V Harrist; Thomas Harvey; Francisco González-Scarano
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

6.  Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid.

Authors:  Francesca Curreli; Hongtao Zhang; Xihui Zhang; Ilya Pyatkin; Zagorodnikov Victor; Andrea Altieri; Asim K Debnath
Journal:  Bioorg Med Chem       Date:  2010-11-25       Impact factor: 3.641

7.  In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat).

Authors:  Catherine S Adamson; Sherimay D Ablan; Ioana Boeras; Ritu Goila-Gaur; Ferri Soheilian; Kunio Nagashima; Feng Li; Karl Salzwedel; Michael Sakalian; Carl T Wild; Eric O Freed
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 8.  HIV-1 Capsid Inhibitors as Antiretroviral Agents.

Authors:  Suzie Thenin-Houssier; Susana T Valente
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

9.  Human serum protein enhances HIV-1 replication and up-regulates the transcription factor AP-1.

Authors:  Maria F Perdomo; Waltteri Hosia; Alenka Jejcic; Garry L Corthals; Anders Vahlne
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-09       Impact factor: 11.205

10.  Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles.

Authors:  Wei-Hao Liao; Kuo-Jung Huang; Yu-Fen Chang; Shiu-Mei Wang; Ying-Tzu Tseng; Chien-Cheng Chiang; Jaang-Jiun Wang; Chin-Tien Wang
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.